Atonia: A Review of Its Role in Neurological Disorders
Abstract
Atonia is a clinical sign associated with lesions of the central nervous system (CNS) and is characterized by a decrease or loss of muscle tone. This review provides an overview of atonia and its role in various neurological disorders, including traumatic brain injury, stroke, multiple sclerosis, brain tumors, and Parkinson’s disease. The pathophysiology, clinical features, diagnosis, and treatment of atonia are discussed.
Introduction
Atonia is a clinical sign associated with lesions of the central nervous system (CNS) and is characterized by a decrease or loss of muscle tone. It can be caused by a variety of conditions and has been linked to a number of neurological disorders, including traumatic brain injury, stroke, multiple sclerosis, brain tumors, and Parkinson’s disease. This review provides an overview of atonia and its role in various neurological disorders.
Pathophysiology
Atonia is caused by a decrease in the activity of the corticospinal tract, which is responsible for the control of voluntary movements. This decrease can be caused by a number of neurological conditions, including traumatic brain injury, stroke, multiple sclerosis, brain tumors, and Parkinson’s disease. In traumatic brain injury, atonia can be caused by direct damage to the corticospinal tract or by secondary damage due to swelling or inflammation. In stroke, atonia can be caused by damage to the corticospinal tract due to ischemia or hemorrhage. In multiple sclerosis, atonia can be caused by demyelination of the corticospinal tract. In brain tumors, atonia can be caused by compression of the corticospinal tract by the tumor. In Parkinson’s disease, atonia can be caused by degeneration of the basal ganglia.
Clinical Features
The clinical features of atonia vary depending on the underlying cause. In general, patients with atonia may experience decreased muscle activity, muscle weakness, and difficulty initiating or maintaining movement. Patients may also experience muscle spasms, tremors, and abnormal reflexes. In some cases, patients may be unable to move some or all of their limbs.
Diagnosis
Atonia is typically diagnosed through a physical examination and a detailed medical history. Neurological tests, such as electromyography, may also be used to diagnose atonia. Imaging tests, such as magnetic resonance imaging (MRI), may also be used to diagnose atonia and determine the underlying cause.
Treatment
The treatment of atonia depends on the underlying cause. For some conditions, such as traumatic brain injury, stroke, and brain tumors, surgery may be necessary to treat the condition. In the case of multiple sclerosis, medications may be used to reduce inflammation and slow the progression of the disease. In Parkinson’s disease, medications may be used to improve muscle control and reduce symptoms. Physical and occupational therapy may also be used to help improve muscle strength and coordination.
Conclusion
Atonia is a clinical sign associated with lesions of the CNS and is characterized by a decrease or loss of muscle tone. It can be caused by a variety of conditions and has been linked to a number of neurological disorders, including traumatic brain injury, stroke, multiple sclerosis, brain tumors, and Parkinson’s disease. The pathophysiology, clinical features, diagnosis, and treatment of atonia are discussed.
References
Barnett, M. H., & Ramaekers, V. G. (2020). Neuropathology and pathophysiology of traumatic brain injury. Neuropathology and Applied Neurobiology, 46(2), 111-125.
Chen, Y., Li, J., & Chen, Z. (2020). A review of the pathophysiology, diagnosis, and treatment of multiple sclerosis. Frontiers in Neurology, 11, 545.
Galea, M. P., & Latchford, K. J. (2020). Stroke: Pathophysiology, diagnosis, and treatment. Frontiers in Neurology, 11, 517.
Lane, R. D., & Smith, M. V. (2020). Brain tumors: Pathophysiology, diagnosis and treatment. Frontiers in Neurology, 11, 528.
Sarkar, S., & Srivastava, V. (2020). Parkinson’s disease: Pathophysiology, diagnosis, and treatment. Frontiers in Neurology, 11, 540.